Public Health Global

Global Insulin Access Public Health Report

Updated Reviewed by Chandani Patel

Global Insulin Access Public Health Report: Need and Coverage, Demographic and Geographic Distribution, Risk Factors, Screening and Diagnosis, Treatment Coverage, Programmes, Gaps and Outlook

Public Health Dashboard · published data

Insulin Access worldwide: key statistics

Global
Latest published figures for the countries in this report
Country Diabetes (adults, WHO)of adultsHealth spending from abroadof health spending
Bangladesh 17.9% 2022 3.5% 2023
Egypt 27.8% 2022 3.5% 2023
India 22.6% 2022 2.4% 2023
Indonesia 12.8% 2022 0.6% 2023
Kenya 5.6% 2022 20.1% 2023
Nigeria 10.9% 2022 11.3% 2023
Pakistan 30.9% 2022 9.7% 2023
Saudi Arabia 20.8% 2022 0.0% 2023
South Africa 13.9% 2022 2.1% 2023

Sources: World Health Organization, World Bank. A dash means no recent published figure.

Only published figures are shown here, with their year and source. The full report keeps reported cases, survey estimates and modelled estimates apart, and names the data gaps.

Buy the full report

Report snapshot

Global Insulin Access Public Health Report at a glance
TopicInsulin Access
PlaceGlobal
Diabetes (adults) (latest)14.1% of adults (2022)Source: WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 20 Nov 2026.
Report sections16 (table of contents)
Active clinical trials1 worldwideSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Global Insulin Access: Overview and Epidemiological Profile

Many people who need insulin in low- and middle-income countries cannot get or afford it, a century after its discovery. This report covers human insulin, analogue insulin and insulin delivery supplies.

Burden: Prevalence, Incidence and Mortality

The report sets out the scale of need for insulin access worldwide: who needs it, how many are reached and the health problems it addresses, using Prevalence, Premature NCD Deaths (Ages 30–70), Diagnosis and Control Rates, Risk Factor Levels and Access to Essential Medicines.

Demographic Distribution: Age, Gender and Vulnerable Population Groups

Need and coverage are broken down by age (adults 18–39 years, adults 40–59 years, adults 60 years and over and children and adolescents), gender and income, with a focus on older adults, low-income urban residents, rural populations, people with multiple conditions, women and migrant workers.

Geographical Distribution: State, District, Urban and Rural Segmentation

Findings are compared across states, provinces and districts where data allows, and between urban, rural and informal settlement areas, to show where needs are greatest and where gaps between places are widest.

Risk Factors and Social Determinants of Health

Main risk factors include tobacco use, unhealthy diet, physical inactivity, harmful use of alcohol, air pollution and ageing. Income, education, housing, water and sanitation, and gender and social norms are reviewed as social drivers of health.

Awareness and Screening Coverage

The report reviews awareness and uptake of insulin access, and how people in need are found, through screening in primary care, population screening programmes, risk factor surveys and early detection tests, by group and by area.

Diagnosis Rates and Undiagnosed Burden

It compares the number of people who need insulin access with the number reached, to show the coverage gap and which groups are missed.

Treatment, Prevention and Coverage

Treatment and prevention covered include WHO prequalification of insulin, pooled procurement, biosimilar insulin and free insulin for children, with how widely each is delivered and how well it is sustained.

Health Outcomes and Complications

Health outcomes covered include premature death, disability, catastrophic health costs and multiple long-term conditions, and what is known about the effect of insulin access on them.

Healthcare Infrastructure and Accessibility

The report looks at primary care clinics, specialist centres, diagnostics and laboratories and medicine supply, the health workforce, and the physical, financial and distance barriers to care, including how people use public and private services.

Economic and Socioeconomic Burden

Insulin Access worldwide: health cover, spending and research

WHO reports that 4.5 billion people were not fully covered by essential health services in 2021.⁠[1] The world scores 71 out of 100 on the WHO universal health coverage index (2023).⁠[2] People pay 17.3% of all health spending out of their own pockets (2023).⁠[3] ClinicalTrials.gov lists 1 study on Insulin Access that is recruiting, active or about to start worldwide.⁠[4]

[1] World Health Organization, universal health coverage. Checked 14 Nov 2026.

[2] WHO Global Health Observatory, Universal health coverage index (index (0–100)). Retrieved 21 Nov 2026.

[3] World Bank Open Data, Out-of-pocket spending (% of health spending). Retrieved 20 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

It describes what insulin access costs to deliver, who pays for it and the costs that fall on households, including funding from government, donors and NGOs.

Government Initiatives and Public Health Interventions

Worldwide guidance and funding for insulin access include WHO Global Action Plan for the Prevention and Control of NCDs, WHO Best Buys for NCDs, WHO HEARTS Technical Package and UN High-Level Meetings on NCDs. The report reviews national programmes, donor and NGO funding, and what is known about their impact.

Historical Trends and Comparative Analysis

Year-wise trends and changes across survey rounds are shown and compared with peer countries, with the data collection year and reporting period stated for each figure.

Healthcare Gaps and Unmet Needs

The report names gaps in screening, diagnosis, treatment and access, the high-risk and underserved communities most affected, and where reliable data is missing.

Future Burden and Public Health Outlook

It looks ahead at future need for insulin access, the resources it will require and the areas most at risk of falling behind.

Key Findings and Strategic Recommendations

The report closes with key findings, the population groups to prioritise and recommendations on where to target resources. Figures come from WHO STEPS Surveys, WHO Global Health Observatory, Global Burden of Disease (IHME), GLOBOCAN Cancer Estimates (IARC) and National Health Surveys. Reported cases, survey estimates and modelled estimates are kept apart, and missing figures are named as data gaps.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Insulin Access Public Health Report right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Insulin Access Public Health Report in context

Free data on this topic

Quick answers

Frequently asked questions

What is insulin access?
Many people who need insulin in low- and middle-income countries cannot get or afford it, a century after its discovery. This report covers human insulin, analogue insulin and insulin delivery supplies.
What does the report on insulin access worldwide cover?
The report has 16 sections: overview and epidemiological profile; burden; demographic distribution; geographical distribution; risk factors and social determinants of health; awareness and screening coverage; diagnosis rates and undiagnosed burden; treatment, prevention and coverage; health outcomes and complications; healthcare infrastructure and accessibility; economic and socioeconomic burden; government initiatives and public health interventions; historical trends and comparative analysis; healthcare gaps and unmet needs; future burden and public health outlook; key findings and strategic recommendations.
How good is health coverage worldwide?
The world scores 71 out of 100 on the WHO universal health coverage index (2023). Source: WHO Global Health Observatory, Universal health coverage index. Retrieved 21 Nov 2026.
How much of health spending do people pay themselves worldwide?
People pay 17.3% of all health spending out of their own pockets (2023). Source: World Bank Open Data, Out-of-pocket spending. Retrieved 20 Nov 2026.
How is healthcare paid for worldwide?
WHO reports that 4.5 billion people were not fully covered by essential health services in 2021. Source: World Health Organization, universal health coverage. Checked 14 Nov 2026.
How many clinical trials on insulin access are running worldwide?
1 study is recruiting, active or about to start worldwide, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.
Back to Catalogue

Related Public Health reports in Global

See all

Related on diabetes

See the topic